Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kusser, B; Braun, A; Praun, M; Illi, S; von Mutius, E; Roscher, AA
   Polymorphisms in the bradykinin B2 receptor gene and childhood asthma
   BIOLOGICAL CHEMISTRY
   
   B. Kusser et al., "Polymorphisms in the bradykinin B2 receptor gene and childhood asthma", BIOL CHEM, 382(5), 2001, pp. 885-889
2. Saudan, P; Berney, T; Goumaz, C; Morel, P; Martin, PY
   Renal transplantation with donors aged over 50: a long-term, single centreexperience
   SWISS MEDICAL WEEKLY
   
   P. Saudan et al., "Renal transplantation with donors aged over 50: a long-term, single centreexperience", SWISS MED W, 131(9-10), 2001, pp. 117-121
3. Tepel, M; van der Giet, M; Zidek, W
   Efficacy and tolerability of angiotensin II type 1 receptor antagonists indialysis patients using AN69 dialysis membranes
   KIDNEY & BLOOD PRESSURE RESEARCH
   
   M. Tepel et al., "Efficacy and tolerability of angiotensin II type 1 receptor antagonists indialysis patients using AN69 dialysis membranes", KIDNEY BL P, 24(1), 2001, pp. 71-74
4. Woolf, AS; Thiruchelvam, N
   Congenital obstructive uropathy: Its origin and contribution to end-stage renal disease in children
   ADVANCES IN RENAL REPLACEMENT THERAPY
   
   A.S. Woolf e N. Thiruchelvam, "Congenital obstructive uropathy: Its origin and contribution to end-stage renal disease in children", ADV RENAL R, 8(3), 2001, pp. 157-163
5. Charra, B; VoVan, C; Marcelli, D; Ruffet, M; Jean, G; Hurot, JM; Terrat, JC; Vanel, T; Chazot, C
   Diabetes mellitus in Tassin, France: Remarkable transformation in incidence and outcome of ESRD in diabetes
   ADVANCES IN RENAL REPLACEMENT THERAPY
   
   B. Charra et al., "Diabetes mellitus in Tassin, France: Remarkable transformation in incidence and outcome of ESRD in diabetes", ADV RENAL R, 8(1), 2001, pp. 42-56
6. Deltas, CC
   Mutations of the human polycystic kidney disease 2 (PKD2) gene
   HUMAN MUTATION
   
   C.C. Deltas, "Mutations of the human polycystic kidney disease 2 (PKD2) gene", HUM MUTAT, 18(1), 2001, pp. 13-24
7. Eastwood, JB; Corbishley, CM; Grange, JM
   Tuberculosis and the kidney
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   J.B. Eastwood et al., "Tuberculosis and the kidney", J AM S NEPH, 12(6), 2001, pp. 1307-1314
8. Michielsen, P; De Schepper, P
   Trends of analgesic nephropathy in two high-endemic regions with differentlegislation
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   P. Michielsen e P. De Schepper, "Trends of analgesic nephropathy in two high-endemic regions with differentlegislation", J AM S NEPH, 12(3), 2001, pp. 550-556
9. Bouba, I; Koptides, M; Mean, R; Costi, CE; Demetriou, K; Georgiou, I; Pierides, A; Siamopoulos, K; Deltas, CC
   Novel PKD1 deletions and missense variants in a cohort of Hellenic polycystic kidney disease families
   EUROPEAN JOURNAL OF HUMAN GENETICS
   
   I. Bouba et al., "Novel PKD1 deletions and missense variants in a cohort of Hellenic polycystic kidney disease families", EUR J HUM G, 9(9), 2001, pp. 677-684
10. Agildere, AM; Kurt, A; Yildirim, T; Benli, S; Altmors, N
    MRI of neurologic complications in end-stage renal failure patients on hemodialysis: pictorial review
    EUROPEAN RADIOLOGY
    
    A.M. Agildere et al., "MRI of neurologic complications in end-stage renal failure patients on hemodialysis: pictorial review", EUR RADIOL, 11(6), 2001, pp. 1063-1069
11. Bussemaker, E; Passauer, J; Franz, T; Gross, P
    Tryptophan immunoadsorption strongly reduces proteinuria in recurrent nephrotic syndrome
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    E. Bussemaker et al., "Tryptophan immunoadsorption strongly reduces proteinuria in recurrent nephrotic syndrome", NEPH DIAL T, 16(6), 2001, pp. 1270-1272
12. Earle, KA; Porter, KK; Ostberg, J; Yudkin, JS
    Variation in the progression of diabetic nephropathy according to racial origin
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    K.A. Earle et al., "Variation in the progression of diabetic nephropathy according to racial origin", NEPH DIAL T, 16(2), 2001, pp. 286-290
13. Schiavello, T; Burke, V; Bogdanova, N; Jasik, P; Melsom, S; Boudville, N; Robertson, K; Angelicheva, D; Dworniczak, B; Lemmens, M; Horst, J; Todorov, V; Dimitrakov, D; Sulowicz, W; Krasniak, A; Stompor, T; Beilin, L; Hallmayer, J; Kalaydjieva, L; Thomas, M
    Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    T. Schiavello et al., "Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease", NEPH DIAL T, 16(12), 2001, pp. 2323-2327
14. Camilleri, B; Richardson, D; Davison, AM
    Destruction of a cervical vertebra in a patient with end-stage renal failure
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    B. Camilleri et al., "Destruction of a cervical vertebra in a patient with end-stage renal failure", NEPH DIAL T, 16(12), 2001, pp. 2434-2436
15. Ritz, E
    Advances in nephrology: successes and lessons learnt from diabetes mellitus
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    E. Ritz, "Advances in nephrology: successes and lessons learnt from diabetes mellitus", NEPH DIAL T, 16, 2001, pp. 46-50
16. Miyata, T; Saito, A; Kurokawa, K; de Strihou, CV
    Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    T. Miyata et al., "Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity", NEPH DIAL T, 16, 2001, pp. 8-11
17. Nathanson, S; Deschenes, G
    Prognosis of Streptococcus pneumoniae-induced hemolytic uremic syndrome
    PEDIATRIC NEPHROLOGY
    
    S. Nathanson e G. Deschenes, "Prognosis of Streptococcus pneumoniae-induced hemolytic uremic syndrome", PED NEPHROL, 16(4), 2001, pp. 362-365
18. Orth, SR; Viedt, C; Amann, K; Ritz, E
    Endothelin in renal diseases and cardiovascular remodeling in renal failure
    INTERNAL MEDICINE
    
    S.R. Orth et al., "Endothelin in renal diseases and cardiovascular remodeling in renal failure", INTERN MED, 40(4), 2001, pp. 285-291
19. Fagugli, RM; Vanholder, R; De Smet, R; Selvi, A; Antolini, F; Lameire, N; Floridi, A; Buoncristiani, U
    Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    
    R.M. Fagugli et al., "Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis", INT J ARTIF, 24(5), 2001, pp. 256-262
20. Jondeby, MS; De-Los Santos, GG; Al-Ghamdi, AM; Al-Hawas, FA; Mousa, DH; Al-Sulaiman, MH; Al-Khader, AA
    Caring for hemodialysis patients in Saudi Arabia - Past, present and future
    SAUDI MEDICAL JOURNAL
    
    M.S. Jondeby et al., "Caring for hemodialysis patients in Saudi Arabia - Past, present and future", SAUDI MED J, 22(3), 2001, pp. 199-204
21. Marangella, M; Petrarulo, M; Vitale, C; Bagnis, C; Berutti, S; Ramello, A; Amoroso, A
    The primary hyperoxalurias
    RARE KIDNEY DISEASES
    
    M. Marangella et al., "The primary hyperoxalurias", CONTR NEPHR, 136, 2001, pp. 11-32
22. Miyata, T; Akhand, AA; Kurokawa, K; Nakashima, I
    Reactive carbonyl compounds as uremic toxins
    DIALYSIS, DIALYZERS AND SORBENTS: WHERE ARE WE GOING?
    
    T. Miyata et al., "Reactive carbonyl compounds as uremic toxins", CONTR NEPHR, 133, 2001, pp. 71-80
23. Nakayama, H; Shiotani, S; Akiyama, S; Gotoh, H; Tani, M; Akine, Y
    Pharmacokinetic study of human natural beta-interferon in patients with end-stage renal failure
    CLINICAL NEPHROLOGY
    
    H. Nakayama et al., "Pharmacokinetic study of human natural beta-interferon in patients with end-stage renal failure", CLIN NEPHR, 56(5), 2001, pp. 382-386
24. Lang, K; Schindler, S; Forberger, C; Stein, G; Figulla, HR
    Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure
    CLINICAL NEPHROLOGY
    
    K. Lang et al., "Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure", CLIN NEPHR, 56(1), 2001, pp. 44-51
25. Kokot, F
    Nephrology in the 21st century
    NIEREN-UND HOCHDRUCKKRANKHEITEN
    
    F. Kokot, "Nephrology in the 21st century", NIEREN HOCH, 30(2), 2001, pp. 45-53
26. Bonnet, F; Deprele, C; Sassolas, A; Moulin, P; Alamartine, E; Berthezene, F; Berthoux, F
    Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    F. Bonnet et al., "Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis", AM J KIDNEY, 37(4), 2001, pp. 720-727
27. Frimat, L
    Contribution of clinical epidemiology to evidence-based nephrology
    NEPHROLOGIE
    
    L. Frimat, "Contribution of clinical epidemiology to evidence-based nephrology", NEPHROLOGIE, 22(5), 2001, pp. 199-203
28. Labeeuw, M
    Treatment of end stage renal failure by dialysis in the Rhone-Alpes area in France: changes over the period 1993-1999
    NEPHROLOGIE
    
    M. Labeeuw, "Treatment of end stage renal failure by dialysis in the Rhone-Alpes area in France: changes over the period 1993-1999", NEPHROLOGIE, 22(4), 2001, pp. 161-166
29. London, GM; Blacher, J; Pannier, B; Guerin, AP; Marchais, SJ; Safar, ME
    Arterial wave reflections and survival in end-stage renal failure
    HYPERTENSION
    
    G.M. London et al., "Arterial wave reflections and survival in end-stage renal failure", HYPERTENSIO, 38(3), 2001, pp. 434-438
30. Miyata, T; de Strihou, CV; Imasawa, T; Yoshino, A; Ueda, Y; Ogura, H; Kominami, K; Onogi, H; Inagi, R; Nangaku, M; Kurokawa, K
    Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient
    KIDNEY INTERNATIONAL
    
    T. Miyata et al., "Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient", KIDNEY INT, 60(6), 2001, pp. 2351-2359
31. Deegan, PB; Lafferty, ME; Blumsohn, A; Henderson, IS; McGregor, E
    Prognostic value of troponin T in hemodialysis patients is independent of comorbidity
    KIDNEY INTERNATIONAL
    
    P.B. Deegan et al., "Prognostic value of troponin T in hemodialysis patients is independent of comorbidity", KIDNEY INT, 60(6), 2001, pp. 2399-2405
32. Ponticelli, C; Traversi, L; Feliciani, A; Cesana, BM; Banfi, G; Tarantino, A
    Kidney transplantation in patients with IgA mesangial glomerulonephritis
    KIDNEY INTERNATIONAL
    
    C. Ponticelli et al., "Kidney transplantation in patients with IgA mesangial glomerulonephritis", KIDNEY INT, 60(5), 2001, pp. 1948-1954
33. Holdaas, H; Jardine, AG; Wheeler, DC; Brekke, IB; Conlon, PJ; Fellstrom, B; Hammad, A; Holme, I; Isoniemi, H; Moore, R; Rowe, PA; Sweny, P; Talbot, DA; Wadstrom, J; Ostraat, O
    Effect of fluvastatin on acute renal allograft rejection: A randomized multicenter trial
    KIDNEY INTERNATIONAL
    
    H. Holdaas et al., "Effect of fluvastatin on acute renal allograft rejection: A randomized multicenter trial", KIDNEY INT, 60(5), 2001, pp. 1990-1997
34. Randoux, C; Gillery, P; Georges, N; Lavaud, S; Chanard, J
    Filtration of native and glycated beta(2)-microglobulin by charged and neutral dialysis membranes
    KIDNEY INTERNATIONAL
    
    C. Randoux et al., "Filtration of native and glycated beta(2)-microglobulin by charged and neutral dialysis membranes", KIDNEY INT, 60(4), 2001, pp. 1571-1577
35. Elseviers, MM; De Broe, ME
    Relationship between nonphenacetin-combined analgesics and nephropathy
    KIDNEY INTERNATIONAL
    
    M.M. Elseviers e M.E. De Broe, "Relationship between nonphenacetin-combined analgesics and nephropathy", KIDNEY INT, 59(6), 2001, pp. 2370-2370
36. Wada, J; Zhang, H; Tsuchiyama, Y; Hiragushi, K; Hida, K; Shikata, K; Kanwar, YS; Makino, H
    Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis
    KIDNEY INTERNATIONAL
    
    J. Wada et al., "Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis", KIDNEY INT, 59(4), 2001, pp. 1363-1373
37. Leertouwer, TC; Pattynama, PMT; van den Berg-Huysmans, A
    Incidental renal artery stenosis in peripheral vascular disease: A case for treatment?
    KIDNEY INTERNATIONAL
    
    T.C. Leertouwer et al., "Incidental renal artery stenosis in peripheral vascular disease: A case for treatment?", KIDNEY INT, 59(4), 2001, pp. 1480-1483
38. Cattran, DC; Appel, GB; Hebert, LA; Hunsicker, LG; Pohl, MA; Hoy, WE; Maxwell, DR; Kunis, CL
    Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
    KIDNEY INTERNATIONAL
    
    D.C. Cattran et al., "Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial", KIDNEY INT, 59(4), 2001, pp. 1484-1490
39. Medcalf, JF; Harris, KPG; Walls, J
    Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis
    KIDNEY INTERNATIONAL
    
    J.F. Medcalf et al., "Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis", KIDNEY INT, 59(3), 2001, pp. 1128-1133
40. Stokes, MB; Hudkins, KL; Zaharia, V; Taneda, S; Alpers, CE
    Up-regulation of extracellular matrix proteoglycans and collagen type I inhuman crescentic glomerulonephritis
    KIDNEY INTERNATIONAL
    
    M.B. Stokes et al., "Up-regulation of extracellular matrix proteoglycans and collagen type I inhuman crescentic glomerulonephritis", KIDNEY INT, 59(2), 2001, pp. 532-542
41. Ying, WZ; Sanders, PW
    Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats
    KIDNEY INTERNATIONAL
    
    W.Z. Ying e P.W. Sanders, "Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats", KIDNEY INT, 59(2), 2001, pp. 662-672
42. Miyata, T; Sugiyama, S; Saito, A; Kurokawa, K
    Reactive carbonyl compounds related uremic toxicity ("carbonyl stress")
    KIDNEY INTERNATIONAL
    
    T. Miyata et al., "Reactive carbonyl compounds related uremic toxicity ("carbonyl stress")", KIDNEY INT, 59, 2001, pp. S25-S31
43. Macdougall, IC
    Role of uremic toxins in exacerbating anemia in renal failure
    KIDNEY INTERNATIONAL
    
    I.C. Macdougall, "Role of uremic toxins in exacerbating anemia in renal failure", KIDNEY INT, 59, 2001, pp. S67-S72
44. Stoves, J; Bartlett, CN; Newstead, CG
    Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis
    POSTGRADUATE MEDICAL JOURNAL
    
    J. Stoves et al., "Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis", POSTG MED J, 77(911), 2001, pp. 586-588
45. Ankersmit, HJ; Deicher, R; Moser, B; Teufel, I; Roth, G; Gerlitz, S; Itescu, S; Wolner, E; Boltz-Nitulescu, G; Kovarik, J
    Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    H.J. Ankersmit et al., "Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis", CLIN EXP IM, 125(1), 2001, pp. 142-148
46. Wlodek, PJ; Iciek, MB; Milkowski, A; Smolenski, OB
    Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis
    CLINICA CHIMICA ACTA
    
    P.J. Wlodek et al., "Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis", CLIN CHIM A, 304(1-2), 2001, pp. 9-18
47. Chou, FF; Chen, JB; Lee, CH; Chen, SH; Sheen-Chen, SM
    Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism
    ARCHIVES OF SURGERY
    
    F.F. Chou et al., "Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism", ARCH SURG, 136(9), 2001, pp. 1064-1068
48. Foucan, L; Merault, H; Deloumeaux, J; Ekouevi, DK; Kangambega, P; Messerchmitt, C; Gabriel, JM
    Survival analysis of diabetic patients on dialysis in Guadeloupe
    DIABETES & METABOLISM
    
    L. Foucan et al., "Survival analysis of diabetic patients on dialysis in Guadeloupe", DIABETE MET, 26(4), 2000, pp. 307-313
49. Barrou, B; Cluzel, P; Bitker, MO; Hamadi, A; Jacobs, C; Richard, F
    Preservation of the vascular and cardiac capital in patients with chronic renal failure.
    PROGRES EN UROLOGIE
    
    B. Barrou et al., "Preservation of the vascular and cardiac capital in patients with chronic renal failure.", PROG UROL, 10(3), 2000, pp. 361-369
50. Zeisberg, M; Strutz, F; Muller, GA
    Role of fibroblast activation in inducing interstitial fibrosis
    JOURNAL OF NEPHROLOGY
    
    M. Zeisberg et al., "Role of fibroblast activation in inducing interstitial fibrosis", J NEPHROL, 13, 2000, pp. S111-S120
51. Webster, KE; Cramer, SD
    Genetic basis of primary hyperoxaluria type II
    MOLECULAR UROLOGY
    
    K.E. Webster e S.D. Cramer, "Genetic basis of primary hyperoxaluria type II", MOL UROL, 4(4), 2000, pp. 355-363
52. Floege, J; Feehally, J
    IgA nephropathy: Recent developments
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    J. Floege e J. Feehally, "IgA nephropathy: Recent developments", J AM S NEPH, 11(12), 2000, pp. 2395-2403
53. Streit, M; Paredes, BE; Ruegger, S; Brand, CU
    Typical features of calciphylaxis in a patient with end-stage renal failure, diabetes mellitus and oral anticoagulation
    DERMATOLOGY
    
    M. Streit et al., "Typical features of calciphylaxis in a patient with end-stage renal failure, diabetes mellitus and oral anticoagulation", DERMATOLOGY, 200(4), 2000, pp. 356-359
54. Sharma, A; Tripathi, AK; Kalra, OP; Chakrabarty, AK
    Impaired function of neutrophils in uraemic patients
    NATIONAL MEDICAL JOURNAL OF INDIA
    
    A. Sharma et al., "Impaired function of neutrophils in uraemic patients", NAT MED J I, 13(3), 2000, pp. 121-124
55. Panczyk-Tomaszewska, M; Ziolkowska, H; Debinski, A; Sieniawska, M
    Vitamin D metabolite requirements in dialysed children receiving recombinant human growth hormone
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    M. Panczyk-Tomaszewska et al., "Vitamin D metabolite requirements in dialysed children receiving recombinant human growth hormone", NEPH DIAL T, 15(3), 2000, pp. 375-378
56. Demetriou, K; Tziakouri, C; Anninou, K; Eleftheriou, A; Koptides, M; Nicolaou, A; Deltas, CC; Pierides, A
    Autosomal dominant polycystic kidney disease - type 2. Ultrasound, geneticand clinical correlations
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    K. Demetriou et al., "Autosomal dominant polycystic kidney disease - type 2. Ultrasound, geneticand clinical correlations", NEPH DIAL T, 15(2), 2000, pp. 205-211
57. Fouque, D; Wang, P; Laville, M; Boissel, JP
    Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    D. Fouque et al., "Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure", NEPH DIAL T, 15(12), 2000, pp. 1986-1992
58. Horl, WH; Jacobs, C; Macdougall, IC; Valderrabano, F; Parrondo, I; Thompson, K; Carveth, BG
    European Best Practice Guidelines 14-16 - Inadequate response to epoetin
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    W.H. Horl et al., "European Best Practice Guidelines 14-16 - Inadequate response to epoetin", NEPH DIAL T, 15, 2000, pp. 43-50
59. Miyata, T; Ueda, Y; Saito, A; Kurokawa, K
    'Carbonyl stress' and dialysis-related amyloidosis
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    T. Miyata et al., "'Carbonyl stress' and dialysis-related amyloidosis", NEPH DIAL T, 15, 2000, pp. 25-28
60. Tsimaratos, M; Cloarec, S; Roquelaure, B; Retornaz, K; Picon, G; Chabrol, B; Guys, JM; Sarles, J; Nivet, H
    Chronic renal failure and portal hypertension - is portosystemic shunt indicated?
    PEDIATRIC NEPHROLOGY
    
    M. Tsimaratos et al., "Chronic renal failure and portal hypertension - is portosystemic shunt indicated?", PED NEPHROL, 14(8-9), 2000, pp. 856-858
61. Nemeth, I; Turi, S; Haszon, I; Bereczki, C
    Vitamin E alleviates the oxidaitive stress of erythropoietin in uremic children on hemodialysis
    PEDIATRIC NEPHROLOGY
    
    I. Nemeth et al., "Vitamin E alleviates the oxidaitive stress of erythropoietin in uremic children on hemodialysis", PED NEPHROL, 14(1), 2000, pp. 13-17
62. Andre, JL
    Outcome of children with chronic renal failure
    ARCHIVES DE PEDIATRIE
    
    J.L. Andre, "Outcome of children with chronic renal failure", ARCH PED, 7(4), 2000, pp. 343-348
63. Park, MS; Lee, HA; Chu, WS; Yang, DH; Hwang, SD
    Peritoneal accumulation of age and peritoneal membrane permeability
    PERITONEAL DIALYSIS INTERNATIONAL
    
    M.S. Park et al., "Peritoneal accumulation of age and peritoneal membrane permeability", PERIT DIA I, 20(4), 2000, pp. 452-460
64. Cancarini, GC; Sandrini, M; Vizzardi, V; Scaini, P; Mombelloni, S; Pola, A; Maiorca, R
    Long-term peritoneal dialysis outcome in a single center
    PERITONEAL DIALYSIS INTERNATIONAL
    
    G.C. Cancarini et al., "Long-term peritoneal dialysis outcome in a single center", PERIT DIA I, 20, 2000, pp. S121-S126
65. Gainer, JV; Brown, NJ; Bachvarova, M; Bastien, L; Maltais, I; Marceau, F; Bachvarov, DR
    Altered frequency of a promoter polymorphism of the kinin B-2 receptor gene in hypertensive African-Americans
    AMERICAN JOURNAL OF HYPERTENSION
    
    J.V. Gainer et al., "Altered frequency of a promoter polymorphism of the kinin B-2 receptor gene in hypertensive African-Americans", AM J HYPERT, 13(12), 2000, pp. 1268-1273
66. Mun, KC; Kim, HC; Kwak, CS
    Cyanate as a hemolytic factor
    RENAL FAILURE
    
    K.C. Mun et al., "Cyanate as a hemolytic factor", RENAL FAIL, 22(6), 2000, pp. 809-814
67. Descombes, E; Fellay, G
    End-stage renal failure after irbesartan prescription in a diabetic patient with previously stable chronic renal insufficiency
    RENAL FAILURE
    
    E. Descombes e G. Fellay, "End-stage renal failure after irbesartan prescription in a diabetic patient with previously stable chronic renal insufficiency", RENAL FAIL, 22(6), 2000, pp. 815-821
68. Ziolkowska, H; Panczyk-Tomaszewska, M; Debinski, A; Polowiec, Z; Sawicki, A; Sieniawska, M
    Bone biopsy results and serum bone turnover parameters in uremic children
    ACTA PAEDIATRICA
    
    H. Ziolkowska et al., "Bone biopsy results and serum bone turnover parameters in uremic children", ACT PAEDIAT, 89(6), 2000, pp. 666-671
69. Tandler, R; Kondruweit, M; Weyand, M
    Cardiac surgery in patients with dialysis-dependent renal failure
    NIEREN-UND HOCHDRUCKKRANKHEITEN
    
    R. Tandler et al., "Cardiac surgery in patients with dialysis-dependent renal failure", NIEREN HOCH, 29(11), 2000, pp. 573-576
70. Hui, DSC; Wong, TYH; Ko, FWS; Li, TST; Choy, DKL; Wong, KK; Szeto, CC; Lui, SF; Li, PKT
    Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    D.S.C. Hui et al., "Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis", AM J KIDNEY, 36(4), 2000, pp. 783-788
71. Zhang, H; Wada, J; Nanba, K; Kunitomi, M; Hida, K; Nagake, Y; Shikata, K; Makino, H
    Familial interstitial nephritis with progressive renal failure
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    H. Zhang et al., "Familial interstitial nephritis with progressive renal failure", AM J KIDNEY, 36(4), 2000, pp. NIL_86-NIL_90
72. Fernandes, PF; Ellis, PA; Roderick, PJ; Cairns, HS; Hicks, JA; Cameron, JS
    Causes of end-stage renal failure in black patients starting renal replacement therapy
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    P.F. Fernandes et al., "Causes of end-stage renal failure in black patients starting renal replacement therapy", AM J KIDNEY, 36(2), 2000, pp. 301-309
73. Kyriazis, J; Stamatiadis, D; Mamouna, A
    Intradialytic and interdialytic effects of treatment with 1.25 and 1.75 mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    J. Kyriazis et al., "Intradialytic and interdialytic effects of treatment with 1.25 and 1.75 mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis", AM J KIDNEY, 35(6), 2000, pp. 1096-1103
74. Deighan, CJ; Caslake, MJ; McConnell, M; Boulton-Jones, JM; Packard, CJ
    Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    C.J. Deighan et al., "Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation", AM J KIDNEY, 35(5), 2000, pp. 852-862
75. Montagnac, R; Schillinger, F; Lavaud, S
    Advantage of an end-stage renal failure registry. Experience of Champagne-Ardenne
    NEPHROLOGIE
    
    R. Montagnac et al., "Advantage of an end-stage renal failure registry. Experience of Champagne-Ardenne", NEPHROLOGIE, 21(8), 2000, pp. 431-435
76. Adam, A; Blais, C; Loute, G
    Kinins: Their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors.
    NEPHROLOGIE
    
    A. Adam et al., "Kinins: Their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors.", NEPHROLOGIE, 21(4), 2000, pp. 163-172
77. Vigneau, C; Trolliet, P; Labeeuw, M; Pouteil-Noble, C
    Which type of dialysis for the type 2 diabetic patient?
    NEPHROLOGIE
    
    C. Vigneau et al., "Which type of dialysis for the type 2 diabetic patient?", NEPHROLOGIE, 21(4), 2000, pp. 173-178
78. Perales, MCS; Cortes, MJG; Borrego, FJ; Martinez, SF; Borrego, J; del Barrio, PP; Liebana, A; Banasco, VP
    Long-term hemodialysis with 2.5 mEq/L dialysate calcium concentration in relative hypoparathyroidism: Effects on bone mass
    NEFROLOGIA
    
    M.C.S. Perales et al., "Long-term hemodialysis with 2.5 mEq/L dialysate calcium concentration in relative hypoparathyroidism: Effects on bone mass", NEFROLOGIA, 20(3), 2000, pp. 254-261
79. Westhuyzen, J; Healy, H
    Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease
    ANNALS OF CLINICAL AND LABORATORY SCIENCE
    
    J. Westhuyzen e H. Healy, "Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease", ANN CLIN L, 30(2), 2000, pp. 133-143
80. Lee, CT; Lee, CH; Chou, FF; Chang, HW; Cheu, JB
    Increased bone mineral density after desferrioxamine treatment in chronic hemodialysis patients with aluminum bone disease
    DIALYSIS & TRANSPLANTATION
    
    C.T. Lee et al., "Increased bone mineral density after desferrioxamine treatment in chronic hemodialysis patients with aluminum bone disease", DIALYSIS T, 29(11), 2000, pp. 733
81. Feinstein, AR; Heinemann, LAJ; Curhan, GC; Delzell, E; DeSchepper, PJ; Fox, JM; Graf, H; Luft, FC; Michielsen, P; Mihatsch, MJ; Suissa, S; van der Woude, F; Willich, S
    Relationship between nonphenacetin combined analgesics and nephropathy: A review
    KIDNEY INTERNATIONAL
    
    A.R. Feinstein et al., "Relationship between nonphenacetin combined analgesics and nephropathy: A review", KIDNEY INT, 58(6), 2000, pp. 2259-2264
82. Hilgers, KF; Hartner, A; Porst, M; Mai, M; Wittmann, M; Hugo, C; Ganten, D; Geiger, H; Veelken, R; Mann, JFE
    Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury
    KIDNEY INTERNATIONAL
    
    K.F. Hilgers et al., "Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury", KIDNEY INT, 58(6), 2000, pp. 2408-2419
83. Ruggenenti, P; Perna, A; Lesti, M; Pisoni, R; Mosconi, L; Arnoldi, F; Ciocca, I; Gaspari, F; Remuzzi, G
    Pretreatment blood pressure reliably predicts progression of chronic nephropathies
    KIDNEY INTERNATIONAL
    
    P. Ruggenenti et al., "Pretreatment blood pressure reliably predicts progression of chronic nephropathies", KIDNEY INT, 58(5), 2000, pp. 2093-2101
84. Yokoyama, H; Okudaira, M; Otani, T; Sato, A; Miura, J; Takaike, H; Yamada, H; Muto, K; Uchigata, Y; Ohashi, Y; Iwamoto, Y
    Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetesin early-onset diabetes in Japan
    KIDNEY INTERNATIONAL
    
    H. Yokoyama et al., "Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetesin early-onset diabetes in Japan", KIDNEY INT, 58(1), 2000, pp. 302-311
85. Miyata, T; Horie, K; Yeda, Y; Fujita, Y; Izuhara, Y; Hirano, H; Uchida, K; Saito, A; De Strihou, CV; Kurokawa, K
    Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds
    KIDNEY INTERNATIONAL
    
    T. Miyata et al., "Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds", KIDNEY INT, 58(1), 2000, pp. 425-435
86. Wratten, ML; Tetta, C; Ursini, F; Sevanian, A
    Oxidant stress in hemodialysis: Prevention and treatment strategies
    KIDNEY INTERNATIONAL
    
    M.L. Wratten et al., "Oxidant stress in hemodialysis: Prevention and treatment strategies", KIDNEY INT, 58, 2000, pp. S126-S132
87. Juergensen, PH; Murphy, AL; Pherson, KA; Kliger, AS; Finkelstein, FO
    Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis
    KIDNEY INTERNATIONAL
    
    P.H. Juergensen et al., "Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis", KIDNEY INT, 57(6), 2000, pp. 2603-2607
88. Jehle, PM; Ostertag, A; Schulten, K; Schulz, W; Jehle, DR; Stracke, S; Fiedler, R; Deuber, HJ; Keller, F; Boehm, BO; Baylink, DJ; Mohan, S
    Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
    KIDNEY INTERNATIONAL
    
    P.M. Jehle et al., "Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy", KIDNEY INT, 57(2), 2000, pp. 423-436
89. Shioshita, K; Miyazaki, M; Ozono, Y; Abe, K; Taura, K; Harada, T; Koji, T; Taguchi, T; Kohno, S
    Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis
    KIDNEY INTERNATIONAL
    
    K. Shioshita et al., "Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis", KIDNEY INT, 57(2), 2000, pp. 619-631
90. Mocks, J
    Cardiovascular mortality in haemodialysis patients treated with epoetin beta - A retrospective study
    NEPHRON
    
    J. Mocks, "Cardiovascular mortality in haemodialysis patients treated with epoetin beta - A retrospective study", NEPHRON, 86(4), 2000, pp. 455-462
91. Houle, S; Landry, M; Audet, R; Bouthillier, J; Bachvarov, DR; Marceau, F
    Effect of allelic polymorphism of the B-1 and B-2 receptor genes on the contractile responses of the human umbilical vein to kinins
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    S. Houle et al., "Effect of allelic polymorphism of the B-1 and B-2 receptor genes on the contractile responses of the human umbilical vein to kinins", J PHARM EXP, 294(1), 2000, pp. 45-51
92. McLean, PG; Perretti, M; Ahluwalia, A
    Kinin B-1 receptors and the cardiovascular system: regulation of expression and function
    CARDIOVASCULAR RESEARCH
    
    P.G. McLean et al., "Kinin B-1 receptors and the cardiovascular system: regulation of expression and function", CARDIO RES, 48(2), 2000, pp. 194-210
93. Dunn, EJ; Burton, CJ; Feest, TG
    The care of patients with diabetic nephropathy: audit, feedback, and improvement
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    E.J. Dunn et al., "The care of patients with diabetic nephropathy: audit, feedback, and improvement", QJM-MON J A, 92(8), 1999, pp. 443-449
94. Strutz, F; Muller, GA
    Interstitial pathomechanisms underlying progressive tubulointerstitial damage
    KIDNEY & BLOOD PRESSURE RESEARCH
    
    F. Strutz e G.A. Muller, "Interstitial pathomechanisms underlying progressive tubulointerstitial damage", KIDNEY BL P, 22(1-2), 1999, pp. 71-80
95. Halimi, S; Zmirou, D; Benhamou, PY; Balducci, F; Zaoui, P; Maghlaoua, M; Cordonnier, D
    Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas french territories. A second national survey six years apart. (UREMIDIAB 2 study)
    DIABETES & METABOLISM
    
    S. Halimi et al., "Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas french territories. A second national survey six years apart. (UREMIDIAB 2 study)", DIABETE MET, 25(6), 1999, pp. 507-512
96. Farboud, B; Aotaki-Keen, A; Miyata, T; Hjelmeland, LM; Handa, JT
    Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye
    MOLECULAR VISION
    
    B. Farboud et al., "Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye", MOL VIS, 5(11), 1999, pp. NIL_1-NIL_6
97. Suzuki, D; Miyata, T; Saotome, N; Horie, K; Inagi, R; Yasuda, Y; Uchida, K; Izuhara, Y; Yagame, M; Sakai, H; Kurokawa, K
    Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    D. Suzuki et al., "Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions", J AM S NEPH, 10(4), 1999, pp. 822-832
98. Labrousse, L; de Vincentiis, C; Madonna, F; Deville, C; Roques, X; Baudet, E
    Early and long term results of coronary artery bypass grafts in patients with dialysis dependant renal failure
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    
    L. Labrousse et al., "Early and long term results of coronary artery bypass grafts in patients with dialysis dependant renal failure", EUR J CAR-T, 15(5), 1999, pp. 691-696
99. Piehlmeier, W; Renner, R; Schramm, W; Kimmerling, T; Garbe, S; Proetzsch, R; Fahn, J; Piwernetz, K; Landgraf, R
    Screening of diabetic patients for microalbuminuria in primary care - The PROSIT-Project
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    W. Piehlmeier et al., "Screening of diabetic patients for microalbuminuria in primary care - The PROSIT-Project", EXP CL E D, 107(4), 1999, pp. 244-251
100. Matuszkiewicz-Rowinska, J; Skorzewska, K; Radowicki, S; Sokalski, A; Przedlacki, J; Niemczyk, S; Wlodarczyk, D; Puka, J; Switalski, M
     The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis
     NEPHROLOGY DIALYSIS TRANSPLANTATION
     
     J. Matuszkiewicz-Rowinska et al., "The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis", NEPH DIAL T, 14(5), 1999, pp. 1238-1243